Hydrogen-Oxygen Therapy Speeds COVID-19 Recovery in Hospital Patients

Authors
Journal
BMC Infectious Diseases
Year
DOI
10.1186/s12879-023-08424-4
Study Type
Human
Outcome
Positive
Peer Reviewed
Yes
Country
China
Health Condition
COVID-19
Body System
Respiratory

TL;DR

A study found that treating COVID-19 patients with a mix of hydrogen and oxygen gas could shorten their hospital stay and improve their oxygen levels compared to just oxygen therapy.

Key Finding

COVID-19 patients treated with hydrogen/oxygen therapy had a median hospital stay of 12 days compared to 13 days for those receiving oxygen alone, with higher discharge rates at 21 and 28 days.

Summary

This study compared hydrogen/oxygen gas therapy to regular oxygen therapy in 88 COVID-19 patients hospitalized across three medical centers. Patients receiving hydrogen/oxygen therapy spent about one day less in the hospital on average (12 days versus 13 days) and had higher discharge rates after 21 and 28 days. They also showed slightly higher oxygen saturation levels (a measure of how much oxygen is in the blood) after five days of treatment.

Practical Takeaway

This small, retrospective study suggests hydrogen/oxygen therapy may modestly reduce hospitalization time in COVID-19 patients, with potentially greater benefits for younger patients without other health conditions. However, the difference in hospital stay was only one day, and this was a single study without long-term follow-up data, so more research is needed to confirm these findings and understand whether the benefits are clinically meaningful.

Abstract (excerpt)

Abstract Background Hydrogen/oxygen therapy contribute to ameliorate dyspnea and disease progression in patients with respiratory diseases. Therefore, we hypothesized that hydrogen/oxygen therapy for ordinary coronavirus disease 2019 (COVID-19) patients might reduce the length of hospitalization…

Read the full abstract via DOI